BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 10936677)

  • 1. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of methylated genes associated with aggressive bladder cancer.
    Marsit CJ; Houseman EA; Christensen BC; Gagne L; Wrensch MR; Nelson HH; Wiemels J; Zheng S; Wiencke JK; Andrew AS; Schned AR; Karagas MR; Kelsey KT
    PLoS One; 2010 Aug; 5(8):e12334. PubMed ID: 20808801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization, expression pattern and immunologic function of
    Liu Y; Bai Y; Chen S; Pu F; Li Y; Chi H; Zheng Z; Xu P; Zhou T
    Front Immunol; 2024; 15():1301877. PubMed ID: 38370405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of a Possible Role of SNPs in KAI1 Gene on Its Down-Regulation in Breast Cancer.
    Kussaibi H; Alkharsah KR
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2549-2553. PubMed ID: 32986351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
    Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
    Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
    [No Abstract]   [Full Text] [Related]  

  • 6. TIMP-1 and CD82, a promising combined evaluation marker for PDAC.
    Zhang J; Wu T; Zhan S; Qiao N; Zhang X; Zhu Y; Yang N; Sun Y; Zhang XA; Bleich D; Han X
    Oncotarget; 2017 Jan; 8(4):6496-6512. PubMed ID: 28030805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI-1 and p53 expression in oral squamous cell carcinomas: Markers of significance in future diagnostics and possibly therapeutics.
    Patil NN; Wadhwan V; Chaudhary M; Nayyar AS
    J Oral Maxillofac Pathol; 2016; 20(3):384-389. PubMed ID: 27721601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nm23-H1 was involved in regulation of KAI1 expression in high-metastatic lung cancer cells L9981.
    You J; Chang R; Liu B; Zu L; Zhou Q
    J Thorac Dis; 2016 Jun; 8(6):1217-26. PubMed ID: 27293840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation impact analysis of erythropoietin (EPO) Gene to hypoxia inducible factor-1α (HIF-1α) activity.
    Dewi FR; Fatchiyah F
    Bioinformation; 2013; 9(15):782-7. PubMed ID: 24023421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
    Tsai YC; Weissman AM
    FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
    Liu W; Iiizumi-Gairani M; Okuda H; Kobayashi A; Watabe M; Pai SK; Pandey PR; Xing F; Fukuda K; Modur V; Hirota S; Suzuki K; Chiba T; Endo M; Sugai T; Watabe K
    J Biol Chem; 2011 May; 286(21):18949-59. PubMed ID: 21454613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanins: push and pull in suppressing and promoting metastasis.
    Zöller M
    Nat Rev Cancer; 2009 Jan; 9(1):40-55. PubMed ID: 19078974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester enhances KAI1 transcription by recruiting Tip60/Pontin complexes.
    Rowe A; Weiske J; Kramer TS; Huber O; Jackson P
    Neoplasia; 2008 Dec; 10(12):1421-32, following 1432. PubMed ID: 19048121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of human breast cancer metastasis.
    Debies MT; Welch DR
    J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):441-51. PubMed ID: 12013533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
    Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
    Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.
    Jackson P; Millar D; Kingsley E; Yardley G; Ow K; Clark S; Russell PJ
    Cancer Lett; 2000 Sep; 157(2):169-76. PubMed ID: 10936677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.